Endurant Capital Management’s NxStage Medical Inc. NXTM Stock Holding History

Endurant Capital Management’s Portfolio NXTM Stock Details NXTM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-46,513	Closed	-$1.3M	–	80
2018 Q3	$1.3M	Buy	+46,513	New	+$1.31M	0.58%	40
2017 Q3	–	Sell	-108,300	Closed	-$2.71M	–	107
2017 Q2	$2.71M	Buy	+108,300	New	+$2.68M	0.77%	38
2016 Q2	–	Sell	-26,400	Closed	-$396K	–	99
2016 Q1	$396K	Buy	+26,400	New	+$442K	0.13%	76
2015 Q3	–	Sell	-87,293	Closed	-$1.25M	–	102
2015 Q2	$1.25M	Buy	87,293 +20,200	+30%	+$342K	0.37%	59
2015 Q1	$1.16M	Buy	+67,093	New	+$1.19M	0.38%	66

Other funds holding NXTM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

TAL

TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

WCMNY

Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Endurant Capital Management's NXTM Position: Q4 2018 in Review

Endurant Capital Management sold out of NxStage Medical Inc. (NXTM) in Q4 2018, closing a stake of 46,513 shares — an estimated $1.3M sold.

Endurant Capital Management first reported a position in NXTM in Q1 2015 and held it in 5 quarters. The position peaked at $2.71M in Q2 2017. 172 funds tracked by Wall St. Rank hold NXTM as of Q4 2018.

Endurant Capital Management reported no remaining NxStage Medical Inc. position as of Q4 2018 after selling out during the quarter.
Endurant Capital Management sold 46,513 NxStage Medical Inc. shares in Q4 2018, an estimated $1.3M.
Endurant Capital Management first reported a position in NxStage Medical Inc. in Q1 2015 and held it in 5 quarters.
Endurant Capital Management's NxStage Medical Inc. position peaked at $2.71M in Q2 2017.
172 funds tracked by Wall St. Rank held NxStage Medical Inc. as of Q4 2018.

Based on Endurant Capital Management's 13F filing for Q4 2018, filed 14 Feb 2019.